Ethical issues for vaccines and immunization

Nature Reviews Immunology

Volumn 2, Issue 4, 2002, Pages 291-296

  Ulmer, Jeffrey B ^a   Liu, Margaret A ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b TRANSGENE S A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

DEVELOPED COUNTRY; DEVELOPING COUNTRY; EPIDEMIOLOGICAL DATA; ETHICS; HEALTH CARE DELIVERY; HEALTH CARE DISTRIBUTION; HEALTH ECONOMICS; HUMAN; IMMUNIZATION; JUSTICE; MEDICAL DECISION MAKING; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; VACCINATION; ARTICLE; CHILD; HEALTH CARE AND PUBLIC HEALTH; INFANT;

HEALTH CARE AND PUBLIC HEALTH;

CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; ETHICS; HUMANS; IMMUNIZATION; INFANT; VACCINES;

EID: 0036546815     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri780     Document Type: Review

References (22)

1. Ten great public health achievements - United States, 1900-1999. MMWR Morb. Mortal. Wkly Rep. 48, 241-243 (1999).
2. Impact of vaccines universally recommended for children - United States, 1990-1998. MMWR Morb. Mortal. Wkly Pep. 48, 243-248 (1999).
3. Global Alliance for Vaccines and Immunizations. Global immunization challenges [online], 〈http://www.vaccinealliance.org/reference/ globalimmcha Ilenges.html〉
4. Rice, A. L., Sacco, L., Hyder, A., & Black, R. E. Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bull. World Health Organ. 78, 1207-1221 (2000).
5. Hinman, A Eradication of vaccine-preventable diseases. Annu. Rev. Public Health 20, 211-229 (1999).
6. World Health Organization. State of the World's Vaccine and immunizations (in the press)
7. Feudtner, C. & Marcuse, E. K. Ethics and immunization policy: promoting dialogue to sustain consensus. Pediatrics 107, 1158-1164 (2001).
8. Foege, W. in New Generation Vaccines (eds Levin, M., Woodrow, G., Kaper, J. & Cobon, G.) 97 (Marcel Dekker, New York, 1997).
9. Wilson, C. B. & Marcuse, E. K. Vaccine safety-vaccine benefits: science and the public's percepion Nature Rev Immunol. 1, 160-165 (2001).
10. Henderson, D. A. Eradication: lessons from the past. Bull. World Health Organ. 76,17-21 (1998).
11. Henderson, D. A. Primary health care as a practical means for measles control. Rev. Infect. Dis. 5, 606-607 (1983).
12. Ada, G. in New Generation Vaccines 2nd edn (eds Levine, M. et al.) 13-24 (Marcel Dekker, New York, 1997).
13. Wakefield, A. et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children, Lancet 351, 637-641 (1998).
14. Birmingham, K. UK immunization highs and lows, Nature Med. 7, 135 (2001).
15. Duffell, E. Attitudes of parents towards measles and immunisation after a measles outbreak in an anthroposophical community J. Epidemiol. Community Health 55, 685-686 (2001).
16. Bazin, H. The ethics of vaccine usage in society: lessons from the past. Curr. Opin. Immunol. 13, 505-510 (2001).
17. Hinman, A. Eradication of vaccine-preventable diseases. Annu. Rev. Public Health 20, 211-229 (1999).
18. Instussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Morb. Mortal. Wkly Rep. 48, 577-581 (1999).
19. Wilde, H. What are today's orphaned vaccines? Clin. Infect. Dis. 33, 648-650 (2001).
20. Jimenez, J. Vaccines - a wonderful tool for equity in health. Vaccine 19, 2201-2205 (2001).
21. Vandermissen, W. WHO expectation and industry goals. Vaccine 19, 1611-1615 (2001).
22. Department of Vaccines and Biologicals, WHO Vaccine-Preventable Diseases: Monitoring System 2001 Global Summary (World Health Organization, Geneva, 2001) 〈 http://www.who.int/vaccinesdocuments/GlobalSummary/GlobalSummary.pdf〉